Charrier M.J.S., Savage G.P., Vanhanen L., 2002. Oxalate contents and calcium binding capacity of tea and herbal teas. Asia Pac. J. Clin. Nutr. 11: 298-301.
Curhan G., Willett W., Rimm E., Stampfer M., 1997. Family history and risk of kidney stones. J. Am. Soc. Nephrol. 8: 1568-1573.
Galli V., Barbas C., 2004. Capillary electrophoresis for the analysis of short-chain organic acids in coffee. J. Chromatogr. A 1032: 299-304.
Gasińska A., Gajewska D., 2007. Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones. Rocz. PZH 58: 61-67.
Holmes R.P., Assimos D.G., 2004. The impact of dietary oxalate on kidney stone formation. Urol. Res. 32: 311-316.
Honow R., Hesse A., 2002. Comparison of extraction methods for the determination of soluble and total oxalate in foods by HPLC-enzyme-reactor. Food Chem. 78: 511-521.
Low oxalate diet, 2003. University of Pittsburgh Medical Center, Pittsburgh, USA. [http:// www.upmc.com/HealthAtoZ/patienteducation/Documents/LowOxalateDiet.pdf].
Marcason W., 2006. Where can i find information on the oxalate content of foods? J. Am. Diet. Assoc. 106: 627-628.
Massey L.K., 2007. Food oxalate: factors affecting measurement, biological variation, and bioavailability. J. Am. Diet. Assoc. 107: 1191-1194.
McKay D., Seviour P., Comerford A., Vasdev S., Massey M.K., 1995. Herbal tea: an altemative to regular tea for those who form calcium oxalate stones. J. Am. Diet. Assoc. 95: 360-361.
Noonan S.C., Savage G.P., 1999. Oxalate content of foods and its effect on humans. Asia Pac. J. Clin. Nutr. 8: 64-74.
Porowski T., Zoch-Zwierz W., Porowska H., Jedaszko I., 2006. Stężenie anionu szczawianowego w osoczu dzieci leczonych antybiotykami P-laktamowymi. Pol. Merk. Lek. 20: 159-163.
Ramello A., Vitale C., Marangella M., 2000. Epidemiology of nephrolithiasis. J. Nephrol. 13: 45-50.
Serio A., Fraioli F., 1999. Epidemiology of nephrolithiasis. Nephron 81: 26-30.
Siener R., Hesse A., 2002. The effect of different diets on urine composition and the risk of calcium oxalate crystallization in healthy subjects. Eur. Urol. 42: 289-296.
Stamatelou K., Francis M.E., Jones C.A., Nyberg L.M., Curhan G.C., 2003. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63: 1817-1823.
Stanisz A., 2007. Przystępny kurs statystyki z zastosowaniem Statistica PL na przykładach z medycyny. T. 3. Analizy wielowymiarowe. StatSoft, Kraków.
Tałataj M., Toboła M., Marcinowska-Suchowierska E., 2009. Kamica układu moczowego - prewencja i leczenie farmakologiczne. Post. Nauk Med. 5: 387-394.
Thorleifsson G., Holm H., Edvardsson V., Walters G.B., Styrkarsdottir U., Gudbjarts- son D.F., Sulem P., Halldorsson B.V., De vegt F., D’ancona F.C., Den Heijer M., Franzson L., Christiansen C., Alexandersen P., Rafnar T., Kristjansson K., Sigurds- son G., Kiemeney L.A., Bodvarsson M., Indridason O.S., Palsson R., Kong A., Thorste- insdottir U., Stefansson K., 2009. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat. Genet. 41: 926-930.
Tsai J.Y., Huang J.K., Wu T.T., Lee Y.H., 2005. Comparison of oxalate content in foods and beverages in Taiwan. J. Taiwan Urol. Assoc. 16: 93-98.
Zarembski P.M., Hodkinson A., 1962. The oxalic acid content of English diets. Br. J. Nutr. 16: 627-634.